Salicylic acid derivative compounds and uses thereof

CN122255175APending Publication Date: 2026-06-23NEURODAWN PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NEURODAWN PHARM CO LTD
Filing Date
2024-12-23
Publication Date
2026-06-23

AI Technical Summary

Technical Problem

Existing anti-cerebral ischemia drugs are difficult to achieve satisfactory clinical efficacy, and there is a lack of practical and effective prevention and treatment measures. How to develop new and highly effective anti-cerebral ischemia drugs with multiple functions is an important issue of global concern.

Method used

A class of salicylic acid derivatives is provided that can significantly improve ischemic symptoms in rats with a cerebral ischemia-reperfusion model, and can be used to prepare drugs for the prevention and treatment of stroke. The specific compounds are shown in Formula I.

Benefits of technology

This compound can significantly improve ischemic symptoms in rats with a cerebral ischemia-reperfusion model, reduce the volume of cerebral infarction, and improve neurological deficit symptoms, showing potential for multiple pharmacological effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005202655530000011
    Figure BDA0005202655530000011
  • Figure BDA0005202655530000021
    Figure BDA0005202655530000021
  • Figure BDA0005202655530000022
    Figure BDA0005202655530000022
Patent Text Reader

Abstract

The application discloses a salicylic acid derivative compound and application thereof. The compound can significantly improve ischemic symptoms of a cerebral ischemia-reperfusion model rat, and has a wide application prospect in preparation of a drug for preventing and treating stroke.
Need to check novelty before this filing date? Find Prior Art